Multi-Site Pathological Images-Guided ViT for Oral Squamous Cell Carcinoma Recurrence Prediction

NCT ID: NCT06638762

Last Updated: 2024-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1325 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

Head and neck squamous cell carcinoma is one of the most common cancers. Postoperative recurrence is a risk factor for poor prognosis and decreased survival rate. There is a lag and passivity in the diagnosis and monitoring of postoperative recurrence in clinical diagnosis and treatment. The application of artificial intelligence to explore and develop a model for predicting postoperative recurrence of oral squamous cell carcinoma is expected to solve clinical difficulties and guide the formulation of postoperative monitoring and diagnosis and treatment plans.

Materials and Methods: We recruited patients diagnosed with oral squamous cell carcinoma who had received surgical treatment, collected patient follow-up information and postoperative pathological images, enhanced and standardized pathological images, and extracted pathological features through visual transformation model (ViT). The features of pathological images were fused into a multi-layer perceptron model (MLP) for training, verification and testing, and the predictive performance of the model was evaluated by various indexes.

Results:

Among the 1325 patients enrolled, 275 relapsed, accounting for 20.8%. The optimized ViT-Small model has a validation AUC of 94.79% (90% accuracy) and a test AUC of 95.68% (91.5% accuracy), and outperforms other models on both validation and test sets.

Conclusion:

ViT-Small model have high predictive performance, which is expected to predict postoperative recurrence, guide the formulation of clinical diagnosis and treatment plan.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As the most common tumor in the world, the five-year relative survival rate of head and neck squamous cell carcinoma is about 68%, and the five-year relative survival rate of distant tumors is 40%. More than 60% of patients were diagnosed as locally advanced, the rate of postoperative recurrence was as high as 40%, and the five-year relative survival rate was less than 50%. Tumor metastasis and postoperative recurrence were risk factors for poor prognosis and decreased survival rate, and tumor recurrence occurred almost within 2 years after surgery. The treatment of locally advanced patients often includes postoperative chemoradiotherapy, immunotherapy, etc., and the treatment of early patients is often mainly surgical resection. The problem of over-treatment and missed diagnosis and treatment may occur when guiding postoperative treatment according to clinical or pathological stages, and the risk judgment of postoperative recurrence lacks objective basis and quantitative standard.

In clinical diagnosis and treatment, whether adjuvant treatment is needed after surgery should be considered in combination with the risk of recurrence and pathological risk factors. For the monitoring and diagnosis of postoperative recurrence, regular follow-up of patients, imaging and pathological examination and clinical experience judgment of the attending physician are often required, which has lag and passivity. Prediction of postoperative recurrence, optimization of follow-up plan and timely development of personalized postoperative treatment will effectively reduce postoperative recurrence.

The application of artificial intelligence in the medical field has provided non-invasive diagnosis and support for the diagnosis and screening of oral cancer. Previously, we deeply learned the clinical diagnosis and treatment information and follow-up data of oral cancer patients to establish a model to predict postoperative recurrence of oral cancer. MLP model can predict postoperative recurrence of oral cancer to a certain extent. In order to focus on postoperative pathology, this study establishes a postoperative recurrence prediction model by deep learning of pathological risk factors, which is expected to improve the prediction efficiency and simplify the process, thus guiding the monitoring plan.Deep learning pathological images and the establishment of postoperative recurrence prediction model of oral squamous cell carcinoma through digital pathology have high predictive performance, which is expected to predict postoperative recurrence, guide the formulation of clinical diagnosis and treatment plan, develop personalized treatment plan for patients, reduce postoperative recurrence and improve survival rate.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer of Head and Neck

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgery

We recruited patients diagnosed with oral squamous cell carcinoma who had received surgical treatment, collected patient follow-up information and postoperative pathological images, enhanced and standardized pathological images, and extracted pathological features through visual transformation model.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

\-
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SYSKY-2024-440-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.